Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 442-480-8 | CAS number: 182893-11-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Based on the results of Ames and MLA in vitro studies it is concluded that the test substance is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay or in the the mouse lymphoma L5178Y test system. The cells were exposed to MIKP(in DMP) in DMSO. An in vitro assay for chromosome aberration is not available for the registered substance. Data from a structural analogue is used to for this endpoint, for further information see the attached read across justification in section 13. They key study for MEKP is a mammalian cell cytogenetic assay for chromosome aberration. V79 cell cultures were exposed to MEKP (in TXIB/diacetone alcohol) in DMSO. There was no evidence of chromosome aberration induced over background.
There are also in vitro studies available for MEKP in DMP. These have not been included in this dossier since they were disregarded (assigned a klimisch 3) in the MEKP dossier. In short summary: In the Ames studies MEKP in DMP was negative. In an MLA, sister chromatid exchanges and in vitro chromosome aberration postitive results were seen but only at the highest test concentration where also pronounced cytotoxicity was observed.
The additive DMP is not a mutagenic/clastogenic substance in vivo and has not to classified and labelled with regard to this hazard.
Based on these results further in vivo investigations are not required.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22 January 2002 - 31 January 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Qualifier:
- according to guideline
- Guideline:
- JAPAN: Guidelines for Screening Mutagenicity Testing Of Chemicals
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- histidine + typtophan operon
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Additional strain / cell type characteristics:
- other: see below
- Species / strain / cell type:
- E. coli WP2 uvr A
- Additional strain / cell type characteristics:
- other: see below
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix
- Test concentrations with justification for top dose:
- 1st experiment:
all strains: 10, 33, 100, 333, 1000, 3330 and 5000 µg/plate in the absence and presence of 5% (v/v) S9-mix.
2nd experiment:
TA1535, TA1537, TA98 and TA100
With and without S9-mix: 10, 33, 100, 333 and 1000 µg/plate
WP2uvrA
Without S9-mix: 10, 33, 100, 333, 1000 and 2000 µg/plate.
With S9-mix : 10, 33, 100, 333 and 1000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: no data - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: see below
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in agar (plate incorporation)
DURATION
- Preincubation period: NA
- Exposure duration: 48 hours
SELECTION AGENT (mutation assays): histidine/tryptophan
NUMBER OF REPLICATIONS: At least five different doses (increasing with approximately half-log steps) of the test substance were tested in triplicate in each strain.
NUMBER OF CELLS EVALUATED: The revertant colonies (histidine independentc c.q. tryptophan independent) were counted automatically with a Protos model 50000 colony counter or manually, if less than 40 colonies per plate were present.
DETERMINATION OF CYTOTOXICITY
- Method: reduction of the bacterial background lawn - Evaluation criteria:
- No formal hypothesis testing was done.
A test substance is considered negative (not mutagenic) in the test if:
a) The total number of revertants in any tester strain at any concentration is not greater than two times the solvent control value, with or without metabolic activation.
b) The negative response should be reproducible in at least one independently repeated experiment.
A test substance is considered positive (mutagenic) in the test if:
a) It induces at least a 2-fold, dose related increase in the number of revertants with respect to the number induced by the solvent control in any of the tester strains, either with or without metabolic activation.
However, any mean plate count of less than 20 is considered to be not significant.
b) The positive response should be reproducible in at least one independently repeated experiment.
The preceding criteria were not absolute and other modifying factors might enter into the final evaluation decision - Statistics:
- None
- Key result
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- see results table
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- see results table
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- see results table
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- see results table
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS: Not examined
RANGE-FINDING/SCREENING STUDIES: Combined with first experiment
COMPARISON WITH HISTORICAL CONTROL DATA: Yes
ADDITIONAL INFORMATION ON CYTOTOXICITY: None - Conclusions:
- Interpretation of results (migrated information):
negative
Based on the results of this study it is concluded that the test substance is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay. - Executive summary:
The substance was tested in the Salmonella typhimurium reverse mutation assay with four histidine-requiring strains of Salmonella typhimurium (TA1535, TA1537, TA100 and TA98) and in the Escherichia coli reverse mutation assay with a tryptophan-requiring strain of Escherichia coli WP2uvrA. The test was performed in two independent experiments in the presence and absence of S9-mix (Aroclor-1254 induced rat liver S9-mix).
In the combined range finding test/first mutation assay, MIKP was tested up to concentrations of 5000 µg/plate in the absence and presence of S9-mix. MIPK did not precipitate on the plates at this dose level. Toxicity was observed in all tester strains. In the second mutation assay, it was tested up to concentrations of 1000 µg/plate in the absence and presence of S9-mix in the strains TA1535, TA1537, TA98 and TA100. TRIGONOX R-938 was tested up to concentrations of 2000 and 1000 µg/plate in the absence and presence of S9-mix, respectively in strain WP2uvrA. Toxicity was observed in all tester strains. The presence of 5 and 10% (v/v) liver microsomal activation did not influence these findings.
In the second experiment in tester strain TA1537, MIKP induced an up to 2.5-fold increase in the absence of S9-mix. However, this increase was only observed in one experiment and the highest number of revertants was not higher than 20 and within our historical control data range. Therefore, this increase is considered to be not biologically relevant and the test substance is considered to be not mutagenic.
All other bacterial strains showed negative responses over the entire dose range, i.e. no doserelated, two-fold, increase in the number of revertants in two independently repeated experiments.
The negative and strain-specific positive control values were within our laboratory background historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
Based on the results of this study it is concluded that MIPKP is not mutagenic in the Salmonella typhimurium reverse mutation assay and in the Escherichia coli reverse mutation assay.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 18 March 2002 - 22 April 2002
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.17 (Mutagenicity - In Vitro Mammalian Cell Gene Mutation Test)
- GLP compliance:
- yes
- Type of assay:
- mammalian cell gene mutation assay
- Target gene:
- thymidine kinase (TK)
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix
- Test concentrations with justification for top dose:
- Experiment 1:
Without S9-mix: 0.5, 1,5, 10,20,30,40,50,60,70,80 and 90 µg/ml exposure medium.
With 8% (v/v) S9-mix: 1, 10, 30, 50, 70, 100, 130, 175, 230, 275 and 300 µg/ml exposure medium.
Experiment 2:
Without 59-mix: 10,50,75,100,130,175,200,225,250,275,300 and 325 µg/ml exposure medium.
With 12% (v/v) 59-mix: 10, 50, 100, 130, 175, 225, 250, 275, 300, 325 and 350 µg/ml exposure medium. - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle:no data - Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: see below
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration:
Experiment 1: 3 hours
Experiment 2: 24 hours
- Expression time (cells in growth medium):
Experiment 1: 3 days
Experiment 2: 2 days
- Selection time (if incubation with a selection agent): 10-11 days
- Fixation time (start of exposure up to fixation or harvest of cells): 14-15 days
SELECTION AGENT (mutation assays): TK
NUMBER OF REPLICATIONS: Single cultures per test concentration with independent repeat.
NUMBER OF CELLS EVALUATED:
The colonies were divided into small and large colonies. Mutant cells that have suffered extensive genetic damage have prolonged doubling times and thus form small colonies. Less severe affected mutant cells have grown at rates similar to the parental cells and form large colonies. The small colonies can be associated with the induction of chromosomal mutations. The large colonies appeared to result from mutants with single gene mutations (substitutions, deletions of base-pairs) affecting the TK gene.
The small colonies are morphological dense colonies with a sharp contour and with a diameter less than a quarter of a well. The large colonies are morphological dense colonies with a hazy contour and with a diameter larger than a quarter of a well.
DETERMINATION OF CYTOTOXICITY
- Method: relative total growth - Evaluation criteria:
- A mutation assay was considered acceptable if it met the following criteria:
a) The absolute cloning efficiency of the solvent controls was ≥ 50%.
b) In at least seven of the eight doses of the test substance, an acceptable number of surviving cells (10E6) could be analysed for expression of the TK mutation.
c) The spontaneous mutant frequency in the untreated or solvent control was < 10 per 10E5 clonable cells.
d) The positive controls (ethylmethanesulfonate and dimethylnitrosamine) induced significant (at least three-fold) increases in the mutant frequencies. - Statistics:
- The experimental results were not subjected to statistical analysis.
A test substance was considered positive (mutagenic) in the mutation assay if:
a) It induced at least a 3-fold increase in the mutant frequency compared to the solvent control in a dose-dependent manner; and
b) The results were reproducible in an independently repeated test.
A test substance was considered negative (not mutagenic) in the mutation assay if:
a) None of the tested concentrations showed a mutant frequency of at least three-fold compared to the solvent control.
b) The results were confirmed in an independently repeated test. - Key result
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- see table
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- see table
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- RANGE-FINDING/SCREENING STUDIES:
In the dose range finding test, L5178Y mouse lymphoma cells were treated with a test substance concentration range of 1 to 333 µg/ml in the absence of S9-mix with a 3 and 24 hour treatment period and in the presence of S9-mix with a 3 hour treatment period.
In the absence of S9-mix after 3 hours of treatment, no toxicity in the suspension growth was observed up to concentrations of 33 µg/ml compared to the suspension growth of the solvent control. No cell survival was observed at test substance concentrations of 100 and 333 µg/ml after 3 hours treatment.
In the presence of S9-mix after 3 hours of treatment, no toxicity in the suspension growth was observed up to concentrations of 100 µg/ml compared to the suspension growth of the solvent control. No cell survival was observed at the test substance concentration of 333 µg/ml after 3 hours treatment and 24 hours of subculture.
In the absence of S9-mix after 24 hours of treatment, no toxicity in the suspension growth was observed up to concentrations of 100 µg/ml compared to the suspension growth of the solvent control. No cell survival was observed at the test substance concentration of 333 µg/ml after 24 hours of treatment.
COMPARISON WITH HISTORICAL CONTROL DATA: Yes
ADDITIONAL INFORMATION ON CYTOTOXICITY: None - Conclusions:
- Interpretation of results (migrated information):
negative
In conclusion, MIPKP is not mutagenic in the TK mutation test system under the experimental conditions described in this report. - Executive summary:
This report describes the effects of MIPKP on the induction of forward mutations at the thymidine-kinase locus (TK-Iocus) in L5178Y mouse lymphoma cells in the presence and absence of S9-mix. The test was performed in two independent experiments in the presence and absence of S9-mix (Aroclor-1254 induced rat liver S9-mix). A range finding study was performed to set dose levels for the subsequent mutation studies and to establish the solubility of MIPKP. The test substance precipitated in the exposure medium at a test substance concentration of 325 µg/ml. In the first experiment, it was tested up to concentrations of 90 and 300 µg/ml in the absence and presence of 8 % (v/v) S9-mix, respectively. Incubation time was 3 hours.
Appropriate toxicity was observed at these dose levels in the absence and presence of S9-mix. In the second experiment, MIPKP was tested up to concentrations of 225 and 350 µg/ml in the absence and presence of 12 % (v/v) S9-mix, respectively. Incubation times were 24 hours and 3 hours for incubations in the absence and presence of S9 metabolic activation respectively. Toxicity was observed at the dose level of 225 µg/ml in the absence of S9-mix. In the presence of S9-mix, it was tested beyond the limit of the solubility and showed no toxicity at this dose level.
Mutant frequencies in cultures treated with positive control chemicals were increased by 11- and 40-fold for EMS in the first and second experiment respectively, and by 13- and 10-fold for DMN, in the first and second experiment respectively. It was therefore concluded that the test conditions, both in the absence and presence of S9-mix, were appropriate for the detection of a mutagenic response and that the metabolic activation system (S9-mix) functioned properly.
MIPKP did not induce a significant increase in the mutant frequency in the absence or presence of S9 metabolic activation in the first experiment. This result was confirmed in a second, repeat experiment with modifications in the duration of treatment in the absence of S9, and in the composition of the S9 concentration for metabolic activation.
It is concluded that MIPKP is not mutagenic in the mouse lymphoma L5178Y test system under the experimental conditions described in this report.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 2010
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- See attached justification in section 13
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: DME
- Properly maintained: yes
- Checked for Mycoplasma contamination: yes
- Periodically checked for karyotype stability: no data
- Periodically "cleansed" against high spontaneous background: no data - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- mammalian microsomal fraction (S9 mix)
- Test concentrations with justification for top dose:
- Experiment A with 3/20 h treatment/sampling time
without S9 mix: 9.76, 19.53, 29.29, 39.06, 58.59 µg/mL
with S9 mix: 9.76, 19.53, 29.29, 39.06, 58.59 µg/mL
Experiment B with 20/20 h treatment/sampling time
without S9 mix: 4.88, 9.76, 19.53, 39.06, 58.59 µg/mL
Experiment B with 20/28 h treatment/sampling time
without S9 mix: 4.88, 9.76, 19.53, 39.06, 58.59 µg/mL
Experiment B with 3/28 h treatment/sampling time
with S9 mix: 4.88, 9.76, 19.53, 39.06, 58.59, 78.12 µg/mL - Vehicle / solvent:
- - Solvent used: DMSO
- Justification for choice of solvent: no data; however, DMSO is a standard solvent used in studies of this type and a concurrent solvent control was included. - Untreated negative controls:
- yes
- Remarks:
- Dulbecco's Modified Eagle's (DME) medium
- Negative solvent / vehicle controls:
- yes
- Remarks:
- DMSO in DME medium
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- ethylmethanesulphonate
- Remarks:
- without metabolic activation
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- N-dimethylnitrosamine
- Remarks:
- with meatbolic activation
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Preincubation period: 24 hours
- Exposure duration: 3 or 20 hours
- Expression time (cells in growth medium): 20 or 28 hours
- Fixation time (start of exposure up to fixation or harvest of cells): after 20 or 28 hours (after expression time)
SPINDLE INHIBITOR (cytogenetic assays): colchicine
STAIN (for cytogenetic assays): Giemsa stain (5 %)
NUMBER OF REPLICATIONS: duplicate cultures
NUMBER OF CELLS EVALUATED: at least 200 metaphase cells containing 2 N ± 2 centromeres
DETERMINATION OF CYTOTOXICITY
- Method: % cells in relation to solvent control
OTHER EXAMINATIONS:
- Determination of polyploidy: yes
- Determination of endoreplication: yes - Evaluation criteria:
- – the number of aberrations found in the negative and /or solvent controls falls within the range of historical laboratory control data.
– the positive control items produce biologically relevant increases in the number of cells with structural chromosome aberrations. - Statistics:
- A Chi square test was performed.
- Key result
- Species / strain:
- Chinese hamster lung fibroblasts (V79)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: no effects
- Effects of osmolality: no effects
- Precipitation: no precipitation was noted for examined test concentrations
RANGE-FINDING/SCREENING STUDIES:
Based on the results of a pre-test (cytotoxicity) the concentrations indicated in section "Test concentrations" were selected
COMPARISON WITH HISTORICAL CONTROL DATA:
The observed chromosome aberration rates were within the ranges of historical control data. - Remarks on result:
- other: all strains/cell types tested
- Conclusions:
- Interpretation of results (migrated information):
negative
The test item was non-clastogenic in this system. - Executive summary:
In a mammalian cell cytogenetic assay for chromosome aberration, V79 cell cultures were exposed to methyl-ethylketone peroxide (in TXIB and diacetone alcohol) in DMSO at (i) 9.76, 19.53, 29.29, 39.06 and 58.59 µg/mL (without and without S9 mix) with 3 hours treatment and 20 hours sampling time, at (ii) 4.88, 9.76, 19.53, 39.06 and 58.59 µg/mL (without S9 mix) with 20 hours treatment and 20 hours sampling time or with 20 hours treatment and 28 hours sampling time and at (iii) 4.88, 9.76, 19.53, 39.06, 58.59 and 78.12 µg/mL with 3 hours treatment and 28 hours sampling time. The results of a pretest on cytotoxicity were used as basis for dose level selection. Methyl-ethylketone peroxide was tested up to cytotoxic concentrations with and without metabolic activation. Positive controls induced the appropriate responses. There was no evidence of chromosome aberration induced over background.
This study is classified as acceptable. This study satisfies the requirement for test guideline OECD 473 for in vitro cytogenetic mutagenicity data.
Referenceopen allclose all
In the second experiment in tester strain TA1537, MIPKP induced an up to 2.5-fold increase in the absence of S9-mix. However, this increase was only observed in one experiment and the highest number of revertants was not higher than 20 and within our historical control data range. Therefore, this increase is considered to be not biologically relevant and the test substance is considered to be not mutagenic. All other bacterial strains showed negative responses over the entire dose range, i.e. no dose related, two-fold, increase in the number of revertants in two independently repeated experiments.
The negative and strain-specific positive control values were within our laboratory background historical control data ranges indicating that the test conditions were adequate and that the metabolic activation system functioned properly.
The spontaneous mutant frequencies in the solvent-treated control cultures were between the minimum and maximum value of the historical control data range ({0.7- and 6.3 x 10E5 (mean 2.7 x 10E5 ) in the absence of S9-mix} and {0.7- and 6.9 x 10E5 (mean 3.1 x 10E5 ) in the presence of S9mix}; for n=164 and 151 respectively).
Mutant frequencies in cultures treated with positive control chemicals were increased by 11- and 40-fold for EMS in the first and second experiment respectively, and by 13- and 10-fold for DMN, in the first and second experiment respectively. It was therefore concluded that the test conditions, both in the absence and presence of S9-mix, were appropriate for the detection of a mutagenic response and that the metabolic activation system
(S9-mix) functioned properly.
Mutant frequency at the TK-Iocus
The test substance did not induce a significant increase in the mutant frequency in the absence or presence of S9 metabolic activation in the first experiment. This result was confirmed in a second, repeat experiment with modifications in the duration of treatment in the absence of S9, and in the composition of the S9 concentration for metabolic activation.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Justification for classification or non-classification
The substance substance is not mutagenic in the Ames test or the MLA. A structural analogue is negative in an in vitro chromosome aberration assay. Therefore the test substance is not classified for genetic toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.